113 related articles for article (PubMed ID: 31449498)
1. Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma.
Hosaka S; Fukushima H; Nakao T; Suzuki R; Yamaki Y; Tanaka K; Saito T; Mizumoto M; Sakurai H; Fukushima T; Takada H
J Pediatr Hematol Oncol; 2020 Jan; 42(1):e18-e24. PubMed ID: 31449498
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
Front Oncol; 2020; 10():617506. PubMed ID: 33552991
[TBL] [Abstract][Full Text] [Related]
4. Clinical results of proton beam therapy for advanced neuroblastoma.
Oshiro Y; Mizumoto M; Okumura T; Sugahara S; Fukushima T; Ishikawa H; Nakao T; Hashimoto T; Tsuboi K; Ohkawa H; Kaneko M; Sakurai H
Radiat Oncol; 2013 Jun; 8():142. PubMed ID: 23758770
[TBL] [Abstract][Full Text] [Related]
5. Interinstitutional patient transfers between rapid chemotherapy cycles were feasible to utilize proton beam therapy for pediatric Ewing sarcoma family of tumors.
Nakao T; Fukushima H; Fukushima T; Suzuki R; Hosaka S; Yamaki Y; Kobayashi C; Iwabuchi A; Imagawa K; Sakai A; Shinkai T; Masumoto K; Sakashita S; Masumoto T; Mizumoto M; Sumazaki R; Sakurai H
Rep Pract Oncol Radiother; 2018; 23(5):442-450. PubMed ID: 30197580
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
[No Abstract] [Full Text] [Related]
7. Proton-beam therapy for olfactory neuroblastoma.
Nishimura H; Ogino T; Kawashima M; Nihei K; Arahira S; Onozawa M; Katsuta S; Nishio T
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):758-62. PubMed ID: 17398027
[TBL] [Abstract][Full Text] [Related]
8. Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.
Casey DL; Kushner BH; Cheung NV; Modak S; Basu EM; Roberts SS; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):409-414. PubMed ID: 30763661
[TBL] [Abstract][Full Text] [Related]
9. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2016 Jul; 5(7):1519-25. PubMed ID: 27165972
[TBL] [Abstract][Full Text] [Related]
10. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma.
Kraal KC; van Dalen EC; Tytgat GA; Van Eck-Smit BL
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010349. PubMed ID: 28429876
[TBL] [Abstract][Full Text] [Related]
11. Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection.
Ono T; Nakamura T; Azami Y; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
Thorac Cancer; 2019 Feb; 10(2):289-295. PubMed ID: 30585704
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy for olfactory neuroblastoma.
Nakamura N; Zenda S; Tahara M; Okano S; Hayashi R; Hojo H; Hotta K; Kito S; Motegi A; Arahira S; Tachibana H; Akimoto T
Radiother Oncol; 2017 Mar; 122(3):368-372. PubMed ID: 28062086
[TBL] [Abstract][Full Text] [Related]
13. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
Pai Panandiker AS; Beltran C; Billups CA; McGregor LM; Furman WL; Davidoff AM
Pediatr Blood Cancer; 2013 May; 60(5):761-5. PubMed ID: 23024112
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of stage 3 neuroblastoma.
Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma.
Gillis AM; Sutton E; Dewitt KD; Matthay KK; Weinberg V; Fisch BM; Chan A; Gooding C; Daldrup-Link H; Wara WM; Farmer DL; Harrison MR; Haas-Kogan D
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):858-64. PubMed ID: 17517478
[TBL] [Abstract][Full Text] [Related]
16. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
Imaizumi M; Watanabe A; Kikuta A; Takano T; Ito E; Shimizu T; Tsuchiya S; Iinuma K; Konno T; Ohi R; Hayashi Y;
Tohoku J Exp Med; 2001 Oct; 195(2):73-83. PubMed ID: 11846211
[TBL] [Abstract][Full Text] [Related]
17. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.
Kim TW; Choi E; Park J; Shin DH; Jung SK; Seok S; Cho KH; Kim JY; Kim DY; Kim TH; Suh YK; Kim YJ; Moon SH
Cancer Res Treat; 2018 Apr; 50(2):335-344. PubMed ID: 28421723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
